STOCK TITAN

Veradigm (NASDAQ: MDRX) files 12b-25, cites restatements and Nasdaq delisting

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
NT 10-K

Rhea-AI Filing Summary

Veradigm Inc. filed a Form 12b-25 notifying the SEC that it cannot timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 because completing comprehensive financial statements requires unreasonable effort and expense. The company attributes the delay to prior misstatements and internal control failures that led to restatements of prior years, the March 18, 2025 filing of its restated 2022 Form 10-K, and ongoing remediation and audit work. The filing notes Nasdaq delisting actions initiated in February 2024 and a Form 25 filed on April 25, 2024. The company references a $100 million senior secured term loan entered in June 2025 and states it is working to file the historical late reports and the 2025 Form 10-K but gives no definitive filing date or assurance of relisting.

Positive

  • None.

Negative

  • None.

Insights

Late filing stems from prior restatements and unresolved internal control weaknesses.

The notice documents that consolidated financial statements for prior years were restated and that internal control failures affected revenue and balance sheet reporting. The company filed a restated 2022 Form 10-K on March 18, 2025, and remediation and audit procedures for later years remain ongoing.

Remediation timing is uncertain; material risks include additional adjustments or identified material weaknesses. Subsequent periodic filings should disclose resolved control status, any additional corrections, and auditor opinions.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

SEC FILE NUMBER 000-32085

CUSIP NUMBER 01988P108

 

 

 

(Check one): 

Form 10-K  Form 20-F  Form 11-K  Form 10-Q

Form 10-D  Form N-CEN  Form N-CSR

 

 

 

For Period Ended: December 31, 2025

 

 

 

Transition Report on Form 10-K

 

 

 

Transition Report on Form 20-F

 

 

 

Transition Report on Form 11-K

 

 

 

Transition Report on Form 10-Q

 

 

 

For the Transition Period Ended:  

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: Not Applicable

PART I — REGISTRANT INFORMATION

VERADIGM INC.

Full Name of Registrant

Not Applicable

Former Name if Applicable

222 Merchandise Mart

Address of Principal Executive Office (Street and Number)

Chicago, Illinois 60654

City, State and Zip Code

 


 

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

 

 

 

 

(a)

The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

(c)

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III — NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

(Attach extra Sheets if Needed)

Veradigm Inc. (the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Form 10-K”). The Company has determined that it is unable to file the 2025 Form 10-K within the prescribed time period provided by the applicable rules of the U.S. Securities and Exchange Commission (the “SEC”) without unreasonable effort and expense.

On March 22, 2023, the Company’s Board of Directors (the “Board”), after discussion with management, reached a determination that the Company’s consolidated financial statements and related disclosures as of and for the year ended December 31, 2021 included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as of and for the interim periods ended March 31, 2021, June 30, 2021 and September 30, 2021 included in its Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2021, June 30, 2021 and September 30, 2021, respectively, and as of and for the interim periods ended March 31, 2022, June 30, 2022 and September 30, 2022 included in its Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2022, June 30, 2022 and September 30, 2022, respectively (such interim periods collectively, the “Interim Periods”), should no longer be relied upon because of misstatements to the Company’s previously reported revenue resulting from certain internal control failures. On February 27, 2025, the Board, after discussion with management, reached a determination that the Company’s consolidated financial statements and related disclosures as of and for the year ended December 31, 2020 included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 should no longer be relied upon because of misstatements to the Company’s consolidated balance sheet and income statement identified in connection with the procedures conducted by the Company in connection with the audit of the Company’s financial statements as of and for the year ended December 31, 2022.

The Company did not file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “2022 Form 10-K”), which included a restatement of the Company’s consolidated financial statements and related disclosures as of and for the years ended December 31, 2021 and December 31, 2020, and as of and for each of the Interim Periods, until March 18, 2025, because of the internal control failures and the time taken to conduct the investigation and reviews described in the 2022 Form 10-K. As a result of this delay and the Company’s expectation that it will file a comprehensive Form 10-K for the fiscal year ended December 31, 2023 and the fiscal year ended December 31, 2024, the Company has been unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023 (the “Q1 2023 Form 10-Q”), its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023 (the “Q2 2023 Form 10-Q”), its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023 (the “Q3 2023 Form 10-Q” and, together with the Q1 2023 Form 10-Q and the Q2 2023 Form 10-Q, the “2023 Form 10-Qs”), its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Form 10-K”), its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “Q1 2024

 


 

Form 10-Q”), its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024 (the “Q2 2024 Form 10-Q”), its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024 (the “Q3 2024 Form 10-Q” and, together with the Q1 2024 Form 10-Q and the Q2 2024 Form 10-Q, the “2024 Form 10-Qs”), its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “2024 Form 10-K”), its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025 (the “Q1 2025 Form 10-Q”), its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025 (the “Q2 2025 Form 10-Q”) or its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2025 (the “Q3 2025 Form 10-Q” and, together with the Q1 2025 Form 10-Q and the Q2 2025 Form 10-Q, the “2025 Form 10-Qs”) and, together with the 2023 Form 10-Qs, the 2023 Form 10-K, the 2024 Form 10-Qs, the 2024 Form 10-K, and the 2025 Form 10-Qs, the “Historical Late Filings”). Accordingly, the Company has also not yet filed the 2025 Form 10-K.

On February 27, 2024, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel determined to delist the common stock of the Company from Nasdaq due to the Company remaining noncompliant with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the SEC, and Nasdaq Listing Rule 5620(a), which requires companies listing common stock to hold an annual meeting of stockholders no later than one year after the end of the company’s fiscal year. On April 25, 2024, Nasdaq filed a Form 25 with the SEC to delist the common stock of the Company from Nasdaq.

The Company is working diligently to file the Historical Late Filings and the 2025 Form 10-K; however, no assurance can be given as to the definitive date on which such periodic reports will be filed or whether the Company will ultimately return to being listed on The Nasdaq Global Select Market in the future.

PART IV — OTHER INFORMATION

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

Name and telephone number of person to contact in regard to this notification

 

 

 

 

 

 

 

 

 

Leland Westerfield

   800   

334-8534

 

 

(Name)

 

(Area Code)

 

(Telephone Number)

 

 

 

(2)

 

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes No

 

 

 

 

 

During the preceding twelve months, the 2024 Form 10-K, Q1 2025 Form 10-Q, Q2 2025 Form 10-Q and Q3 2025 Form 10-Q have not been filed. In addition, the Q1 2023 Form 10-Q, Q2 2023 Form 10-Q, Q3 2023 Form 10-Q, 2023 Form 10-K, Q1 2024 Form 10-Q, Q2 2024 Form 10-Q and Q3 2024 Form 10-Q have not been filed.

 

 

 

(3)

 

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes No

 

 

 

 

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

DISCLOSURE REGARDING FORWARD-LOOKING INFORMATION

This Form 12b-25 contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding the anticipated timing of the filing of the Historical Late Filings and the 2025 Form 10-K and the Company’s expectations regarding the earnings statements to be included in the 2025 Form 10-K. These forward-looking

 


 

statements are based on the current beliefs and expectations of the Company’s management with respect to future events, only speak as of the date that they are made and are subject to significant risks and uncertainties. Such statements can be identified by the use of words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “could,” “continue,” “can,” “may,” “look forward,” “aims,” “hopes” and “seeks” and similar terms, although not all forward-looking statements contain such words or expressions. Actual results could differ significantly from those set forth in the forward-looking statements.

Important factors that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, risks relating to the Company’s common stock not trading on a national securities exchange and deregistration from Section 12(b) of the Securities Exchange Act of 1934, as amended; a further material delay in the Company’s financial reporting or ability to hold an annual meeting of stockholders; an inability of the Company to timely prepare its delinquent financial statements; unanticipated factors or factors that the Company currently believes will not cause further delay; the Company’s remediation efforts and preparation of financial statements or other factors that could cause additional delay or adjustments; the possibility that ongoing remediation work or the audit of the Company’s financial statements for the fiscal years ended December 31, 2023, December 31, 2024 or December 31, 2025 may identify additional errors and material weaknesses or other deficiencies in the Company’s accounting practices; the likelihood that the control deficiencies identified or that may be identified in the future will result in additional material weaknesses in the Company’s internal control over financial reporting; risks relating to the putative securities class action lawsuit filed against the Company, the putative stockholder derivative action filed against the Company, commercial litigation relating to the Company’s representations regarding its financial statements and any other future litigation or investigation relating to the Company’s internal control failures, the completed investigation and reviews or related matters; changes in the financial condition of the markets that the Company serves; the Company’s ability to hire qualified individuals to serve in senior leadership roles on a permanent basis; risks associated with the Company’s incurrence of additional debt and the terms and conditions of the Company’s $100 million senior secured term loan credit facility entered into in June 2025; and other factors contained in the “Risk Factors” section and elsewhere in the 2022 Form 10-K and the Company’s other filings with the SEC from time to time. The Company does not undertake to update any forward-looking statements to reflect changed assumptions, the impact of circumstances or events that may arise after the date of the forward-looking statements, or other changes over time, except as required by law.

Veradigm Inc.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

 

 

 

Date: March 17, 2026

 

By:

 

/s/ Leland Westerfield

 

 

 

 

 

Leland Westerfield

 

 

 

 

 

Interim Chief Financial Officer

 

 


FAQ

Why did Veradigm (MDRX) file Form 12b-25 for its 2025 10-K?

Veradigm cites prior misstatements and internal control failures that require comprehensive remediation and audit work before filing. The company says completing the financial statements would involve unreasonable effort and expense given ongoing reviews and restatements.

Has Veradigm previously restated financial statements?

Yes. The company states it determined that prior years’ consolidated financial statements contained misstatements and filed a restated 2022 Form 10-K on March 18, 2025 covering periods including 2020 and 2021.

Is Veradigm facing Nasdaq delisting actions?

Yes. Nasdaq’s panel determined to delist the common stock for failure to timely file periodic reports; Nasdaq filed a Form 25 on April 25, 2024. The company notes no assurance it will return to Nasdaq listing.

What financing obligations does Veradigm reference in the filing?

The notice references a $100 million senior secured term loan facility entered into in June 2025. The filing lists this credit facility as a material factor in its risk disclosures.

Which periodic reports remain unfiled according to the notice?

The company lists multiple delinquent reports, including the 2023 Form 10-K, the 2024 Form 10-K, and several quarterly Form 10-Qs for 2023–2025, as well as the 2025 Form 10-K that is the subject of this notice.
Veradigm

OTC:MDRX

View MDRX Stock Overview

MDRX Rankings

MDRX Latest News

MDRX Latest SEC Filings

MDRX Stock Data

516.19M
104.05M
Health Information Services
Healthcare
Link
United States
Chicago